Cargando…
Repurposing Approach Identifies Auranofin with Broad Spectrum Antifungal Activity That Targets Mia40-Erv1 Pathway
Current antifungal therapies have limited effectiveness in treating invasive fungal infections. Furthermore, the development of new antifungal is currently unable to keep pace with the urgent demand for safe and effective new drugs. Auranofin, an FDA-approved drug for the treatment of rheumatoid art...
Autores principales: | Thangamani, Shankar, Maland, Matthew, Mohammad, Haroon, Pascuzzi, Pete E., Avramova, Larisa, Koehler, Carla M., Hazbun, Tony R., Seleem, Mohamed N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241286/ https://www.ncbi.nlm.nih.gov/pubmed/28149831 http://dx.doi.org/10.3389/fcimb.2017.00004 |
Ejemplares similares
-
In vivo evidence for cooperation of Mia40 and Erv1 in the oxidation of mitochondrial proteins
por: Böttinger, Lena, et al.
Publicado: (2012) -
A single-cysteine mutant and chimeras of essential Leishmania Erv can complement the loss of Erv1 but not of Mia40 in yeast
por: Specht, Sandra, et al.
Publicado: (2017) -
Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci
por: AbdelKhalek, Ahmed, et al.
Publicado: (2018) -
Correction for Precursor Oxidation by Mia40 and Erv1 Promotes Vectorial Transport of Proteins into the Mitochondrial Intermembrane Space
Publicado: (2014) -
Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens
por: Thangamani, Shankar, et al.
Publicado: (2016)